A case of Schnitzler syndrome complicated by rheumatoid arthritis treated with methotrexate
Modern Rheumatology Case Reports · 2025
DOI: 10.1093/mrcr/rxaf026 ↗Kurz gefasst
Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2025. Verfasst von Kensuke Irino und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan. Hauptthemen laut MEDLINE: Schnitzler Syndrome, Methotrexate, Arthritis, Rheumatoid, Antirheumatic Agents. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Schnitzler syndrome (SchS) is a rare autoinflammatory disorder characterised by recurrent urticaria, monoclonal gammopathy, fever, and arthralgia. We herein report a case of SchS complicated by rheumatoid arthritis (RA). A 78-year-old man presented to our hospital with fever, myalgia, and urticaria, each lasting for ~1 week over the past 8 years. He was diagnosed with SchS based on monoclonal immunoglobulin G gammopathy, chronic urticaria, an intermittent fever, arthritis, high inflammatory markers, and neutrophil infiltration in the dermis on skin biopsy. Although colchicine improved the symptoms slightly, the patient subsequently developed arthritis and was diagnosed with RA based on elevated anti-cyclic citrullinated peptide antibody and rheumatoid factor levels. Methotrexate (MTX), a first-line therapy for RA, was initiated, resulting in a remarkable improvement in both RA and SchS symptoms. This case highlights the rare coexistence of SchS and RA as well as the efficacy of MTX in treating both conditions. Although interleukin (IL)-1 inhibitors are considered the most effective treatment for SchS, they are not approved for SchS in Japan and are expensive. The efficacy of IL-6 inhibitors in SchS has also been reported, and MTX suppresses inflammatory cytokines, including IL-1 and IL-6. As shown in our case, drugs that modulate IL-6 levels, such as MTX, may be a viable treatment option for SchS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan.
- Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan.
- Department of Dermatology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan.
ORCID-Profile: Kensuke Irino
Zitieren
APA
Irino, K., Kochi, Y., Imamura, S., Nabeshima, C., Oka, N., & Sawabe, T. (2025). A case of Schnitzler syndrome complicated by rheumatoid arthritis treated with methotrexate. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxaf026
Vancouver
Irino K, Kochi Y, Imamura S, Nabeshima C, Oka N, Sawabe T. A case of Schnitzler syndrome complicated by rheumatoid arthritis treated with methotrexate. Modern Rheumatology Case Reports. 2025. doi:10.1093/mrcr/rxaf026
BibTeX
@article{Irino2025,
author = {Irino, Kensuke and Kochi, Yu and Imamura, Sakurako and Nabeshima, Chika and Oka, Naoya and Sawabe, Takuya},
title = {A case of Schnitzler syndrome complicated by rheumatoid arthritis treated with methotrexate},
journal = {Modern Rheumatology Case Reports},
year = {2025},
doi = {10.1093/mrcr/rxaf026}
}
EUVIMED